Antibiotic preparations; Antibiotics; Anti-cancer preparations; Anti-infectives; Anti-inflammatories; Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Gastro-intestinal treatment preparations; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 86014025

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 10054033

44D Filed

Yes

44D Current

44E filed

44E Current

Yes

66A Filed

66A Current

Current Basis

No Basis

Design Code(s)

09.09.07 -

Spinning wheels, looms

15.07.25 -

Other wheels including vehicular wheels without spokes; hubcaps

26.01.26 -

Spirals, coils and swirls

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History

Status Date	Action Taken
19^th May 2024	COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27^th Mar 2024	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27^th Mar 2024	TEAS CHANGE OF CORRESPONDENCE RECEIVED
27^th Mar 2024	TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
27^th Mar 2024	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27^th Mar 2024	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27^th Mar 2024	TEAS CHANGE OF OWNER ADDRESS RECEIVED
02^th Apr 2022	NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02^th Apr 2022	REGISTERED - SEC. 8 (6-YR) ACCEPTED
02^th Apr 2022	CASE ASSIGNED TO POST REGISTRATION PARALEGAL

OBI PHARMA

Classification Information

Class [005]Pharmaceutical Products